The regeneration of the dentin–pulp complex is a paradigm shift in restorative dentistry, offering the potential to restore form and function to teeth compromised by disease or trauma. Bioactive dental scaffolds have emerged as a promising technology to facilitate cellular regeneration and tissue integration within the dental pulp space. This article reviews current scientific evidence, mechanisms of action, clinical relevance, and emerging therapies surrounding the application of bioactive scaffolds for dentin–pulp complex regeneration, with a focus on translational and guideline-based insights for dental practitioners and healthcare professionals.
Conventional endodontic therapies, while effective in eliminating infection and preserving tooth structure, do not restore the biological function of the dentin–pulp complex. In recent years, the field of regenerative endodontics has advanced significantly, with bioactive scaffolds at the forefront of efforts to achieve true tissue regeneration. Through the integration of biomaterials, growth factors, and stem cell biology, bioactive scaffolds aim to create a conducive environment for cellular infiltration, angiogenesis, odontogenic differentiation, and functional tissue restoration. This review synthesizes recent research and clinical findings, emphasizing practical considerations for implementation and the challenges that remain.
Pulpal and periapical diseases represent a significant global health burden, affecting millions annually and accounting for a substantial proportion of dental visits. Dental caries, trauma, and restorative procedures are leading etiologies for pulp injury, with untreated cases progressing to necrosis and periapical pathology. The limitations of current treatments, such as root canal therapy, highlight the unmet need for regenerative solutions that can restore the vitality and function of the dentin–pulp complex.
The dentin–pulp complex comprises a dynamic interplay between odontoblasts, pulp fibroblasts, vascular elements, and neural components. Injury or infection disrupts this homeostasis, leading to inflammation, cellular apoptosis, and tissue necrosis. Regeneration requires not only the elimination of pathogens but also the re-establishment of vascularity and innervation, which are essential for long-term tissue viability and function. Bioactive scaffolds seek to recapitulate the natural extracellular matrix, providing cues for stem cell homing, differentiation, and tissue remodeling.
Major risk factors for pulpal pathology include extensive carious lesions, traumatic injuries, repeated restorative interventions, and congenital anomalies affecting tooth development. Systemic conditions such as diabetes and compromised immune status may impair healing potential and influence regenerative outcomes. Recognizing these risk factors is crucial for patient selection and individualized treatment planning in regenerative endodontics.
Acute and chronic pulpal disease often presents with pain, sensitivity, and radiographic changes, ranging from reversible pulpitis to advanced necrosis. Clinically, teeth requiring regenerative intervention may exhibit open apices (particularly in immature permanent teeth), thin dentinal walls, and periapical radiolucencies. Preservation of some vital tissue is often a prerequisite for successful regeneration, underscoring the importance of early diagnosis and intervention.
Diagnosis of pulpal disease and assessment of regenerative potential relies on a combination of clinical examination, sensibility testing, and advanced imaging modalities such as cone-beam computed tomography (CBCT). Recent studies advocate for the use of biomarkers in pulpal blood or exudate to assess inflammation and regenerative capacity. Accurate diagnosis is foundational to case selection and outcome prediction in regenerative endodontic procedures.
Regenerative endodontic procedures (REPs) typically involve disinfection of the root canal system using irrigants such as sodium hypochlorite and EDTA, followed by placement of a bioactive scaffold. The scaffold serves as a three-dimensional matrix supporting cellular migration and differentiation. Commonly used scaffolds include natural matrices (e.g., collagen, blood clot), synthetic polymers (e.g., polyglycolic acid), and composites infused with growth factors or stem cells. A hermetic coronal seal with biocompatible materials such as mineral trioxide aggregate (MTA) is critical to prevent reinfection and support tissue healing.
Recent advances have focused on optimizing scaffold composition and bioactivity. Innovations include the incorporation of bioactive molecules (e.g., bone morphogenetic proteins, vascular endothelial growth factor), nanofiber scaffolds that closely mimic natural extracellular matrix, and the use of autologous or allogeneic stem cells to enhance regenerative outcomes. Preclinical and early clinical trials demonstrate improved vascularization, neurogenesis, and odontogenic differentiation with these advanced scaffolds. Moreover, 3D bioprinting technology is emerging as a customizable approach to scaffold fabrication, allowing precise control over architecture and cellular distribution.
Professional organizations such as the American Association of Endodontists (AAE) and the European Society of Endodontology (ESE) have issued guidelines supporting the use of REPs in immature permanent teeth with necrotic pulps, provided that strict protocols for disinfection and scaffold placement are followed. Key recommendations include minimal instrumentation to preserve stem cells, careful selection of irrigants and medicaments to avoid cytotoxicity, and regular follow-up to monitor healing and root development. The evidence base for regenerative therapies in mature teeth is growing, but routine use in these cases remains investigational.
The regeneration of the dentin–pulp complex using bioactive dental scaffolds represents a transformative advance in endodontic therapy. While significant progress has been made in understanding the mechanisms and optimizing clinical protocols, challenges remain in achieving consistent, predictable outcomes. Ongoing research into scaffold materials, bioactive signaling, and patient-specific factors will continue to refine regenerative strategies. For dental professionals, incorporating evidence-based regenerative approaches offers the potential to improve long-term tooth survival, preserve natural tissue, and enhance patient quality of life.
1.
Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.
2.
Can Alternating Venetoclax Regimens Improve AML Outcomes?
3.
Cancer detection recovered following pandemic disruptions
4.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment
5.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
1.
A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
4.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
5.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Chemotherapy: What to Expect
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation